Added to YB: 2021-03-10
Pitch date: 2021-03-10
ALIM [bullish]
Alimera Sciences, Inc.
-43.76%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Alimera Sciences, Inc., a pharmaceutical company, develops and commercializes prescription ophthalmic retinal pharmaceuticals.
Market Cap
$301.3M
Pitch Price
$9.85
Price Target
N/A
Dividend
N/A
EV/EBITDA
23.91
P/E
-17.76
EV/Sales
3.64
Sector
Pharmaceuticals
Category
N/A
Show full summary:
ALIMERA SCIENCES INC ALIM
A summary for this pitch has not been created yet.
Read full article (0 min)